Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events

Daniel Bos1, Banafsheh Arshi2, Quirijn J A van den Bouwhuijsen1

  • 1Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.

Insights

Intraplaque hemorrhage (IPH) in carotid artery plaques is a significant independent risk factor for stroke and coronary heart disease (CHD). This finding highlights IPH as a potential marker for vulnerable plaques in individuals with subclinical atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Radiology

Background:

  • Atherosclerotic plaque composition, not just size, is increasingly linked to ischemic cardiovascular events.
  • Large-scale population data on plaque composition in asymptomatic individuals are limited.

Purpose of the Study:

  • To investigate the association between carotid plaque composition and the incidence of stroke and coronary heart disease (CHD) in a population-based cohort.
  • To identify specific plaque characteristics, such as intraplaque hemorrhage (IPH), as potential predictors of cardiovascular events.

Main Methods:

  • 1,349 asymptomatic individuals from the Rotterdam Study underwent high-resolution MRI of carotid arteries to assess plaque components (IPH, lipid-rich necrotic core, calcification) and size.
  • Participants were followed for incident stroke and CHD using Cox regression models, adjusting for cardiovascular risk factors.

Main Results:

  • During follow-up, 51 strokes and 83 CHD events occurred.
  • The presence of intraplaque hemorrhage (IPH) was independently associated with increased risk of both stroke and CHD (HR 2.42 and 1.95, respectively).
  • Lipid-rich necrotic core and calcification were not significantly associated with stroke or CHD incidence.

Conclusions:

  • Intraplaque hemorrhage (IPH) in carotid atherosclerotic plaques is an independent risk factor for stroke and CHD.
  • IPH shows promise as a marker of plaque vulnerability in individuals with subclinical atherosclerosis.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
336
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
165
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
150
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
633
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
110
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
131